Intestinal epithelial responses to enteric pathogens: effects onthe tight junction barrier, ion transport, and inflammation
- ATYPICAL BACTERIAL PATHOGENS IN THE INTESTINAL TRACT. Breidenbach, Warren C.; Martin, Alison // American Journal of Gastroenterology;Nov1961, Vol. 36 Issue 5, p513
Presents information on the atypical bacterial pathogens in the intestinal tract. Characteristics of the bacteria in the intestinal tract; Analysis of several patients with intestinal bacteria; Type of drug used to treat intestinal bacteria.
- Role of the gut microbiota in immunity and inflammatory disease. Kamada, Nobuhiko; Seo, Sang-Uk; Chen, Grace Y.; Núñez, Gabriel // Nature Reviews Immunology;May2013, Vol. 13 Issue 5, p321
The mammalian intestine is colonized by trillions of microorganisms, most of which are bacteria that have co-evolved with the host in a symbiotic relationship. The collection of microbial populations that reside on and in the host is commonly referred to as the microbiota. A principal function...
- A parallel diagnostic accuracy study of three molecular panels for the detection of bacterial gastroenteritis. Biswas, J.; Al-Ali, A.; Rajput, P.; Smith, D.; Goldenberg, S. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2014, Vol. 33 Issue 11, p2075
Culture-dependent detection of gastroenteric bacteria is labour-intensive and does not provide results in a clinically relevant time frame. Several commercially available multiplex molecular panels are now available which may be more sensitive and could potentially provide rapid results. We...
- Evaluation of Prebiotic and Probiotic Effects on the Intestinal Gut Microbiota and Histology of Atlantic salmon ( Salmo salar L.). Kristiansen, Mads; Merrifield, Daniel L.; Vecino, Jose L. Gonzalez; Myklebust, Reidar; Ringø, Einar // Journal of Aquaculture & Research Development;Special2012, Vol. 3 Issue S, Special section p1
In the present study the impact on gut microbiology and indigenous gut histology of Atlantic salmon (Salmo salar L.) was investigated following feeding of a control and a prebiotic (EWOS prebiosalÂ®) diet and ex vivo exposure to saline or the probiotic bacterium Carnobacterium divergens. The...
- Beyond Good and Evil in the Oral Cavity: Insights into Host-Microbe Relationships Derived from Transcriptional Profiling of Gingival Cells. Handfield, M.; Baker, H. V.; Lamont, R. J. // Journal of Dental Research;Mar2008, Vol. 87 Issue 3, p203
In many instances, the encounter between host and microbial cells, through a long-standing evolutionary association, can be a balanced interaction whereby both cell types co-exist and inflict a minimal degree of harm on each other. In the oral cavity, despite the presence of large numbers of...
- enteropathogen. // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p781
A definition of the term "enteropathogen," which refers to any microorganism that causes intestinal disease, is presented.
- The Nutritional Connection to 'Leaky Gut' Toohey, Lynn // American Chiropractor;2002, Vol. 24 Issue 4, p18
Characterizes the concept of leaky gut syndrome of the intestinal lining. Influence of tiny leaks in the development of asthma and arthritis; Role of intestinal lining as barrier to invading pathogens; Absorption of large macromolecules.
- Probiotics: An Emerging Therapy. O'Sullivan, G. C.; Kelly, P.; O'Halloran, S.; Collins, C.; Collins, J. K.; Dunne, C.; Shanahan, F. // Current Pharmaceutical Design;Jan2005, Vol. 11 Issue 1, p3
There is considerable clinical interest in the utility of probiotic therapy - the feeding of (live) non-pathogenic bacteria, originally derived from the alimentary tract, for disease treatment or health promotion. The microflora of the gastrointestinal tract is essential for mucosal protection,...
- Rifaximin: A Novel Nonabsorbed Rifamycin for Gastrointestinal Disorders. Adachi, Javier A.; DuPont, Herbert L. // Clinical Infectious Diseases;2/15/2006, Vol. 42 Issue 4, p541
Rifaximin, a virtually nonabsorbed (<0.4%) rifamycin drug, has in vitro activity against aerobic and anaerobic gram-positive and gram-negative microorganisms. Because rifaximin is nonabsorbed, systemic adverse effects are unusual, and after 3 days of therapy, the fecal level of the drug reaches...